Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
Chan Gyu Lee et al, 2021, Frontiers in Pharmacology CrossRef